ATE395055T1 - Pharmazeutische zusammensetzung zur behandlung von hyperhomocysteinämie - Google Patents
Pharmazeutische zusammensetzung zur behandlung von hyperhomocysteinämieInfo
- Publication number
- ATE395055T1 ATE395055T1 AT04104599T AT04104599T ATE395055T1 AT E395055 T1 ATE395055 T1 AT E395055T1 AT 04104599 T AT04104599 T AT 04104599T AT 04104599 T AT04104599 T AT 04104599T AT E395055 T1 ATE395055 T1 AT E395055T1
- Authority
- AT
- Austria
- Prior art keywords
- hyperhomocysteinemia
- treatment
- pharmaceutical composition
- disclosed
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000442A ITRM20030442A1 (it) | 2003-09-26 | 2003-09-26 | Composizione farmaceutica (stressen) per il trattamento di iperomocisteinemia. |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE395055T1 true ATE395055T1 (de) | 2008-05-15 |
Family
ID=30131588
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04104599T ATE395055T1 (de) | 2003-09-26 | 2004-09-22 | Pharmazeutische zusammensetzung zur behandlung von hyperhomocysteinämie |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1518554B1 (de) |
AT (1) | ATE395055T1 (de) |
DE (1) | DE602004013695D1 (de) |
IT (1) | ITRM20030442A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20110847A1 (it) * | 2011-05-13 | 2012-11-14 | Soldato Piero Del | Uso di un composto solforato per il trattamento di iperomocisteinemia e patologie correlate |
CN105560264A (zh) * | 2016-03-11 | 2016-05-11 | 广东伊茗药业有限公司 | 一种含腺苷钴胺的组合物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6054128A (en) * | 1997-09-29 | 2000-04-25 | Wakat; Diane | Dietary supplements for the cardiovascular system |
DE10004651A1 (de) * | 2000-02-03 | 2001-08-16 | Jutta Dierkes | Kombination von blutdrucksenkenden Wirkstoffen mit Wirkstoffen, die den Homocysteinspiegel zu senken vermögen |
US20030054978A1 (en) * | 2001-08-31 | 2003-03-20 | Babish John G. | Arginine compositions for coordinate modification of multiple cardiovascular risk factors |
DE10206159A1 (de) * | 2002-02-14 | 2003-08-28 | Kosmas Kg | Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung |
-
2003
- 2003-09-26 IT IT000442A patent/ITRM20030442A1/it unknown
-
2004
- 2004-09-22 EP EP04104599A patent/EP1518554B1/de not_active Not-in-force
- 2004-09-22 DE DE602004013695T patent/DE602004013695D1/de not_active Expired - Fee Related
- 2004-09-22 AT AT04104599T patent/ATE395055T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ITRM20030442A0 (it) | 2003-09-26 |
EP1518554B1 (de) | 2008-05-14 |
ITRM20030442A1 (it) | 2005-03-27 |
EP1518554A1 (de) | 2005-03-30 |
DE602004013695D1 (de) | 2008-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0316350A (pt) | Diaminotriazóis úteis como inibidores de proteìna cinases | |
ATE495739T1 (de) | Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa | |
ATE484494T1 (de) | Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen | |
EA200700860A1 (ru) | (бифенил)карбоновые кислоты и их производные | |
ATE497495T1 (de) | Zur behandlung von neoplastischen erkrankungen, entzündlichen erkrankungen und erkrankungen des immunsystems geeignete 2,4- di(phenylamino)pyrimidine | |
ATE390407T1 (de) | Phenethanolamin-derivate zur behandlung von atemwegserkrankungen | |
EA200401114A2 (ru) | Замещённые гидроксиэтиламины | |
UY27755A1 (es) | Nuevas composiciones farmacéuticas basadas en anticolinérgicos e inhibidores. | |
EA200500169A1 (ru) | Замещенные производные 1,3-дифенилпроп-2-ен-1-она, получение и применение | |
ATE361084T1 (de) | Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis | |
DE60239648D1 (de) | Pharmazeutische Zusammensetzungen zur Behandlung von Asthma | |
ATE432072T1 (de) | Verwendung von adapalen zur behandlung dermatologischer erkrankungen | |
ATE521357T1 (de) | Verfahren zur behandlung von hepatitis | |
EA200601288A1 (ru) | Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение | |
EA200300929A1 (ru) | Новые лекарственные композиции на основе антихолинергических средств и ингибиторов pde-iv | |
ATE504580T1 (de) | Malonsäureamidderivate als inhibitoren von g- sekretase zur behandlung von alzheimer-krankheit | |
EA200401365A1 (ru) | Способы лечения илеуса | |
ATE548035T1 (de) | Formulierungen zur behandlung von lipoprotein- anormalitäten mit einem statin- und einem methylnicotinamid-derivat | |
ATE350377T1 (de) | Substituierte 3-pyrrolidin-indol-derivate | |
EA200600588A1 (ru) | Соединения, содержащие галоидалкил, как ингибиторы цистеиновых протеаз | |
EA200700407A1 (ru) | Производные хиназолина и их использования при лечении тромбоцитемии | |
ATE524181T1 (de) | Verwendung von 1,4-bis (3-aminoalkyl) piperazin- derivaten bei der behandlung von neurodegenerativen erkrankungen | |
EA200700637A1 (ru) | Соли донепезила, подходящие для получения фармацевтических композиций | |
DE60318839D1 (de) | 2,6-chinolinyl- und 2,6-naphthylderivate und deren verwendungen zur behandlung von vla-4 bezogenen krankheiten | |
DE60233433D1 (de) | PHARMAZEUTISCHE ZUBEREITUNG enthaltend ein Catechin, Ascorbinsäure, Prolin und Lysin ZUR BEHANDLUNG VON NEOPLASTISCHEN KRANKHEITEN |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |